Document is current
Any future updates will be listed below
-
Authors
Collins, Evan https://orcid.org/0000-0003-0774-6975
Langer, Robert https://orcid.org/0000-0003-4255-0492
Anderson, Daniel G. https://orcid.org/0000-0001-5629-4798
-
Funding
Funding for this research was provided by:
Sanofi
U.S. Department of Health & Human Services | National Institutes of Health (R33AI161805-05)
MIT Jameel Clinic
- License Information
-
More Information
Article History
First Online: 1 October 2025
Competing interests
: D.G.A. receives research funding from Sanofi and is a founder of Orna Therapeutics, Soufflé Therapeutics and Combined Therapeutics. R.L. is a co-founder and former member of the board of directors of Moderna. He also serves on the board and has equity in Particles for Humanity. For a full list of entities with which R.L. is involved, compensated or uncompensated, see . E.C. has no competing interests to declare.
